GDFN yields 8.31% · JNJ yields 2.13%● Live data
📍 GDFN pulled ahead of the other in Year 1
Combined, GDFN + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GDFN + JNJ for your $10,000?
GDFN focuses on companies within the aerospace and defense sector, investing in pure-play stocks from defense-related activities and prioritizing innovation. Investments center in three key sub-sectors: defense equipment (robotics, drones, military vehicles, space tech, sensor and networking systems, and advanced weaponry), defense technology (AI, IoT, AR/VR, big data analytics, geospatial intelligence, security scanning solutions), and cyber defense firms protecting critical infrastructure. The fund primarily holds between 15 to 100 companies outside the US and Canada, with up to 25% in emerging markets. Security selection combines top-down sector and bottom-up fundamental and valuation analysis to identify attractively valued companies with strong growth prospects. The fund does not hedge currency risk. The fund may engage in security lending. As an actively managed fund, the adviser continuously monitors and adjusts the portfolio based on market and company developments.
Full GDFN Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.